By Deena Beasley (Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' ...

Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...

CVS Health, which operates the largest U.S. pharmacy benefit manager, will not add Gilead Sciences’ new HIV prevention drug ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

Retailers in the U.S. are increasingly cautious due to tariffs and destocking inventories as cost-conscious consumers tighten ...

Brazilian state-run oil firm Petrobras said on Wednesday that chairman Pietro Mendes has resigned from the role, as well as from his seat on the board of directors. Mendes is set to become a director ...

REPORTS SHARE STAKE OF 39,400 SHARES IN DISNEY- SEC FILING * REPORTS SHARE STAKE OF 44,600 SHARES IN MERCK * DISSOLVES SHARE ...